A multicenter point prevalence survey of healthcare-associated infections in pakistan : findings and implications

Saleem, Zikria and Hassali, Mohamed Azmi and Godman, Brian and Hashmi, Furqan Khurshid and Saleem, Fahad (2019) A multicenter point prevalence survey of healthcare-associated infections in pakistan : findings and implications. American Journal of Infection Control, 47 (4). pp. 421-424. ISSN 0196-6553

[img] Text (Saleem-etal-AJIC-2018-A-multicenter-point-prevalence-survey-of-health-care-associated)
Saleem_etal_AJIC_2018_A_multicenter_point_prevalence_survey_of_health_care_associated.pdf
Accepted Author Manuscript
Restricted to Repository staff only until 22 November 2019.
License: Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 logo

Download (514kB) | Request a copy from the Strathclyde author

    Abstract

    Background: Healthcare–associated infections (HAIs) are seen as a global public health threat, leading to increased mortality and morbidity as well as costs. However, little is currently known about the prevalence of HAIs in Pakistan. Consequently, this multicenter prevalence survey of HAIs was conducted to assess the prevalence of HAIs in Pakistan. Methods: We used the methodology employed by the European Centre for Disease Prevention and Control to assess the prevalence of HAIs in Punjab Province, Pakistan. Data were collected from 13 hospitals using a structured data collection tool. Results: Out of 1,553 hospitalized patients, 130 (8.4%) had symptoms of HAIs. The most common HAI was surgical site infection (40.0%), followed by bloodstream infection (21.5%), and lower respiratory tract infection (14.6%). The prevalence of HAI was higher in private sector hospitals (25.0%) and among neonates (23.8%) and patients admitted to intensive care units (33.3%). Patients without HAIs were admitted mainly to public sector hospitals and adult medical and surgical wards. Conclusions: The study found a high rate of HAIs among hospitals in Pakistan, especially surgical site infections, bloodstream infections, and lower respiratory tract infections. This needs to be addressed to reduce morbidity, mortality, and costs in the future, and further research is planned.